In the latest NCI-MATCH news:
The following appointments were recently approved by the Group co-chairs and are currently in effect.
Al B. Benson, III, MD, FACP, FASCO, is EA's new vice-chair, replacing Joseph A. Sparano, MD.
Dr. Benson is Professor of Medicine in the Division of Hematology and Oncology at Northwestern University Feinberg School of Medicine and Director for Cooperative Groups at the Robert H. Lurie Comprehensive Cancer Center. Within ECOG-ACRIN, Dr. Benson is currently chair of the Data Safety Monitoring Committee (Therapeutic), co-chair of the Cancer Care Delivery Research Committee, co-chair of the NCORP Community Advisory Committee, and the EA Principal Investigator for Northwestern University. He is the former chair of the Gastrointestinal Cancer Committee. He is past president and a current member of the Board of Directors of the National Comprehensive Cancer Network and a current member of the PrECOG, LLC Board of Managers.
Therapeutic Studies Program
Priya Bhosale, MD (The MD Anderson Cancer Center), is the imaging chair for the Gynecologic Cancer Working Group, replacing Susanna L. Lee, MD (Massachusetts General Hospital)
Ronnie A. Sebro, MD, PhD (University of Pennsylvania), is the first imaging chair for the Sarcoma Working Group
Throughout the past year, the leaders of the nine disease-oriented scientific committees and three working groups have been collaborating with the NCORP Advisory Committee and the EA Membership Department to identify individuals to serve as their community co-chairs. The following are the latest appointments approved by the Group co-chairs.
Mitchell I. Edelson, MD (Abington Hospital, an Affiliate of Jefferson Health), is the first community co-chair for the Gynecologic Cancer Working Group
Xin Yao, MD (ThedaCare Regional Cancer Center, Appleton, WI), is the community co-chair for the Gastrointestinal Cancer Committee, replacing P.J. Flynn, MD (Minnesota Oncology/Abbott Northwestern Hospital)
View the full list of scientific leaders in the Therapeutic Studies Program at www.ecog-acrin.org.
At its October 5 meeting, the Principal Investigator Committee voted to add two institutions with voting privileges to the committee:
Also at its October 5th meeting, the Principal Investigator Committee voted to accept requests to change the following voting principal investigators:
Baptist Memorial Health Care / Mid South Minority Underserved NCORP: Philip E. Lammers, MD, replaces Raymond U. Osarogiagbon, MD
Dartmouth College/Dartmouth-Hitchcock Norris Cotton Cancer Center: Keisuke Shirai, MD, replaces Clifford J. Eskey, MD
New York University/NYU Cancer Institute: Catherine M. Diefenbach, MD, replaces Deidre J. Cohen, MD
University of Alabama/UAB Comprehensive Cancer Center: Erica Stringer-Reasor, MD, replaces Carla I. Falkson, MD
View the full PI Committee roster at www.ecog-acrin.org.
The Southeast Clinical Oncology Research Consortium NCORP is now a Main Member of ECOG-ACRIN, with Judith O. Hopkins, MD, as Principal Investigator. With 30+ years of experience, Dr. Hopkins is a Clinical Associate Professor of Medicine with Wake Forest University School of Medicine and a staff physician with Novant Health Forsyth Medical Center in Kernersville, NC. She received her medical degree from the Bowman Gray School of Medicine. No Principal Investigator Committee vote was required to add this site to the EA roster, as its status is non-voting.
ECOG-ACRIN Group Co-Chair Mitchell D. Schnall, MD, PhD (University of Pennsylvania), received the 2020 Potamkin Prize from the Pennsylvania Breast Cancer Coalition on October 16, 2020. Dr. Schnall's clinical research on magnetic resonance imaging (MRI) has led to practice-changing results in breast cancer screening and detection. Most recently, he was part of the landmark ECOG-ACRIN clinical trial EA1141, which examined abbreviated MRI compared to 3D mammography. Schnall and the team of scientists from around the world reported in JAMA that abbreviated MRI was 2.5 times more effective than 3D mammograms in women with dense breasts and at average risk for developing breast cancer--an extremely significant finding. Read a profile of Dr. Schnall.
The American Association for Cancer Research recognized Matthew Schabath, PhD (Moffitt Cancer Center), for the meeting highlights from its Virtual 13th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Dr. Schabath presented the results of a survey of healthcare providers in the ECOG-ACRIN Cancer Research Group. The survey covered attitudes, knowledge, and practice behaviors about LGBTQ patients with cancer.
The National Cancer Institute has appointed Lakshmi N. Rajdev, MD, MS (Lenox Hill Hospital and the Northwell Health Cancer Institute), as Medical Oncologist on the NCI Late Phase Emphasis Central Institutional Review Board (CIRB (LPE CIRB). Dr. Rajdev is chair of the EA Esophagogastric Working Group in the Gastrointestinal Cancer Committee and a member of the Esophagogastric Task Force of the NCI Gastrointestinal Cancer Steering Committee. She also chairs trial EA2165: A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High-Risk Anal Cancer.